JAAD 02/26 Acral Lentiginous Melanoma. Part II. Staging, Surgical Management, The Role of Systemic Therapy, Shortcomings and Future Directions
Acral lentiginous melanoma is rare, easy to overlook, and disproportionately deadly for patients of color. This CME activity explores the epidemiology, molecular landscape, and diagnostic clues that set ALM apart from other melanomas, then moves into staging, surgical management, and the systemic therapies shaping outcomes in advanced disease. Build the clinical instincts to catch ALM earlier and manage it more effectively.
Summary
Availability:
On-Demand
Access expires on Feb 28, 2029
Credit Offered:
1 CME Credit
Recommended

Legal notice
Copyright © 2026 American Academy of Dermatology. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.
Android App Download IOS App Download Powered By